Why Arcutis Biotherapeutics (ARQT) Stock Fell 5.01% in 10 Minutes After Q3 Earnings on Nov 4, 2026
EPS of $0.06 came in below the $0.12 estimate; revenue of $143.92 million came in above the $142.59 million estimate.
- ARQT fell 5.01% in the 10 minutes after the 16:01:25 ET headline, from $31.16 to $29.60.
- 32,709 shares changed hands in those 10 minutes.
- The headline crossed in after-hours trading, 1 minute after the 4:00 ET close.
16:01:25 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| ARQT | 31.16 | 31.16 | 31.24 | 29.60 | +0.25% | -5.01% |
Arcutis Biotherapeutics (ARQT) shares fell 5.01% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 16:01:25 ET on Wednesday, November 4, 2026. EPS of $0.06 came in below the $0.12 estimate; revenue of $143.92 million came in above the $142.59 million estimate.
ARQT in the first 10 minutes
The line that crossed at 16:01:25 ET: “ARQT Q3: EPS 0.06 vs 0.12 est; revenue USD 143.92mln vs USD 142.59mln est”
From a reference price of $31.16 just before the headline, the stock was up 0.25% after one minute and down 5.01%, at $29.60, after 10 minutes. The first minute was nearly flat; the move came after it. 32,709 shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 1 minute after the 4:00 ET close.
Arcutis Biotherapeutics Q3 results against estimates
| Measure | Reported | Estimate | Result |
|---|---|---|---|
| EPS | $0.06 | $0.12 | Miss |
| Revenue | $143.92 million | $142.59 million | Beat |
How ARQT traded after earlier earnings releases
| Report | EPS vs estimate | Revenue vs estimate | First move |
|---|---|---|---|
| Aug 5, 2026 | $0.11 vs $0.03 | $129.86 million vs $118.85 million | +10.15% in 15 min |
Arcutis Biotherapeutics at a glance
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Market value | $4.02 billion (as of Nov 4, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
How did Arcutis Biotherapeutics stock react to its Q3 earnings on November 4, 2026?
The stock fell 5.01% in the 10 minutes after its Q3 results crossed at 16:01:25 ET. EPS of $0.06 came in below the $0.12 estimate; revenue of $143.92 million came in above the $142.59 million estimate.
How far did ARQT move after the headline?
From $31.16 just before the headline to $29.60 10 minutes later, a -5.01% move.
Sources
-
ARQT headline and measured reaction, Nov 4, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free